These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 27766352)

  • 1. Dopamine D
    de Oliveira AR; Reimer AE; Reis FM; Brandão ML
    Exp Brain Res; 2017 Feb; 235(2):429-436. PubMed ID: 27766352
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dopamine D2 receptors modulate the expression of contextual conditioned fear: role of the ventral tegmental area and the basolateral amygdala.
    de Souza Caetano KA; de Oliveira AR; Brandão ML
    Behav Pharmacol; 2013 Aug; 24(4):264-74. PubMed ID: 23751519
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conditioned fear is modulated by D2 receptor pathway connecting the ventral tegmental area and basolateral amygdala.
    de Oliveira AR; Reimer AE; de Macedo CE; de Carvalho MC; Silva MA; Brandão ML
    Neurobiol Learn Mem; 2011 Jan; 95(1):37-45. PubMed ID: 20955808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conditioned fear response is modulated by a combined action of the hypothalamic-pituitary-adrenal axis and dopamine activity in the basolateral amygdala.
    de Oliveira AR; Reimer AE; Reis FM; Brandão ML
    Eur Neuropsychopharmacol; 2013 May; 23(5):379-89. PubMed ID: 22682777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mineralocorticoid receptors in the ventral tegmental area regulate dopamine efflux in the basolateral amygdala during the expression of conditioned fear.
    de Oliveira AR; Reimer AE; Brandão ML
    Psychoneuroendocrinology; 2014 May; 43():114-25. PubMed ID: 24703177
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of dopamine receptors in the ventral tegmental area in conditioned fear.
    de Oliveira AR; Reimer AE; Brandão ML
    Behav Brain Res; 2009 May; 199(2):271-7. PubMed ID: 19111792
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of the mesoamygdala dopaminergic pathway impairs the retrieval of conditioned fear associations.
    Nader K; LeDoux JE
    Behav Neurosci; 1999 Oct; 113(5):891-901. PubMed ID: 10571473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involvement of the dopaminergic system in the consolidation of fear conditioning in hippocampal CA3 subregion.
    Wen JL; Xue L; Wang RH; Chen ZX; Shi YW; Zhao H
    Behav Brain Res; 2015 Feb; 278():527-34. PubMed ID: 25446753
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Social buffering reduces male rats' behavioral and corticosterone responses to a conditioned stimulus.
    Kiyokawa Y; Hiroshima S; Takeuchi Y; Mori Y
    Horm Behav; 2014 Feb; 65(2):114-8. PubMed ID: 24361196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapid Activation of Glucocorticoid Receptors in the Prefrontal Cortex Mediates the Expression of Contextual Conditioned Fear in Rats.
    Reis FM; Almada RC; Fogaça MV; Brandão ML
    Cereb Cortex; 2016 Jun; 26(6):2639-49. PubMed ID: 25976757
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sex differences in the behavioural and hypothalamic-pituitary-adrenal response to contextual fear conditioning in rats.
    Daviu N; Andero R; Armario A; Nadal R
    Horm Behav; 2014 Nov; 66(5):713-23. PubMed ID: 25311689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dopaminergic mechanisms in the conditioned and unconditioned fear as assessed by the two-way avoidance and light switch-off tests.
    Reis FL; Masson S; de Oliveira AR; Brandão ML
    Pharmacol Biochem Behav; 2004 Oct; 79(2):359-65. PubMed ID: 15501313
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Behavioral, central monoaminergic and hypothalamo-pituitary-adrenal axis correlates of fear-conditioned analgesia in rats.
    Finn DP; Jhaveri MD; Beckett SR; Madjd A; Kendall DA; Marsden CA; Chapman V
    Neuroscience; 2006; 138(4):1309-17. PubMed ID: 16426764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. D(1)-like receptors in the nucleus accumbens shell regulate the expression of contextual fear conditioning and activity of the anterior cingulate cortex in rats.
    Albrechet-Souza L; Carvalho MC; Brandão ML
    Int J Neuropsychopharmacol; 2013 Jun; 16(5):1045-57. PubMed ID: 22964037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conditioned and unconditioned fear organized in the periaqueductal gray are differentially sensitive to injections of muscimol into amygdaloid nuclei.
    Martinez RC; de Oliveira AR; Brandão ML
    Neurobiol Learn Mem; 2006 Jan; 85(1):58-65. PubMed ID: 16198609
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of amygdaloid dopamine D2 receptors impairs emotional learning measured with fear-potentiated startle.
    Greba Q; Gifkins A; Kokkinidis L
    Brain Res; 2001 Apr; 899(1-2):218-26. PubMed ID: 11311883
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distinct effects of haloperidol in the mediation of conditioned fear in the mesolimbic system and processing of unconditioned aversive information in the inferior colliculus.
    Muthuraju S; Nobre MJ; Saito VM; Brandao ML
    Neuroscience; 2014 Mar; 261():195-206. PubMed ID: 24384225
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Individual Differences in Animal Stress Models: Considering Resilience, Vulnerability, and the Amygdala in Mediating the Effects of Stress and Conditioned Fear on Sleep.
    Wellman LL; Fitzpatrick ME; Hallum OY; Sutton AM; Williams BL; Sanford LD
    Sleep; 2016 Jun; 39(6):1293-303. PubMed ID: 27091518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conditioned and unconditioned fear organized in the inferior colliculus are differentially sensitive to injections of muscimol into the basolateral nucleus of the amygdala.
    Macedo CE; Martinez RC; Brandão ML
    Behav Neurosci; 2006 Jun; 120(3):625-31. PubMed ID: 16768614
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involvement of dopamine D2 receptors in the induction of long-term potentiation in the basolateral amygdala-dentate gyrus pathway of anesthetized rats.
    Abe K; Niikura Y; Fujimoto T; Akaishi T; Misawa M
    Neuropharmacology; 2008 Dec; 55(8):1419-24. PubMed ID: 18835399
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.